FDA Listening Session
FDA will hold a drug compounding annual listening session, virtually, from 9-11 a.m. ET on June 17. This listening session is an opportunity for stakeholders to voice their views on compounding to the FDA. Dr. Mary Ann Block met with IMC members this week for guidance in using her 5 minute opportunity. Alan Dumoff also plans to testify.